Request Free Sample
×
Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market
ID: MRFR/Pharma/36951-HCR
100 Pages
October 2025
Informe de investigación de mercado de Medicamentos no peptídicos antagonistas del receptor de angiotensina II por vía de administración (oral, intravenosa, subcutánea), por área terapéutica (hipertensión, insuficiencia cardíaca, enfermedad renal crónica), por canal de distribución (farmacias hospitalarias, farmacias minoristas, farmacias en línea), por tipo de formulación (tabletas, inyecciones, formulaciones líquidas) y por región (América del Norte, Europa, América del Sur, Asia-Pacífico, Medio Oriente y África) - Previsión hasta 2034
Las empresas clave en el mercado Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market incluyen
Alcance del informe
FAQs
What is the projected market valuation for Non-Peptide Drugs of Angiotensin II Receptor Antagonists in 2035?
The projected market valuation for Non-Peptide Drugs of Angiotensin II Receptor Antagonists in 2035 is 6.52 USD Billion.
What was the market valuation for Non-Peptide Drugs of Angiotensin II Receptor Antagonists in 2024?
The market valuation for Non-Peptide Drugs of Angiotensin II Receptor Antagonists in 2024 was 4.275 USD Billion.
What is the expected CAGR for the Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market from 2025 to 2035?
The expected CAGR for the Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market during the forecast period 2025 - 2035 is 3.91%.
Which therapeutic area is projected to have the highest market value in 2035?
Chronic Kidney Disease is projected to have the highest market value in 2035, with an expected valuation of 2.4 USD Billion.
What are the leading companies in the Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market?
Key players in the market include Novartis, Boehringer Ingelheim, AstraZeneca, Sanofi, Pfizer, Eli Lilly, Merck & Co., and Teva Pharmaceutical Industries.
How does the market for oral formulations compare to intravenous formulations in 2035?
In 2035, the market for oral formulations is expected to reach 3.8 USD Billion, while intravenous formulations are projected to reach 1.5 USD Billion.
What distribution channel is anticipated to generate the highest revenue by 2035?
Hospital Pharmacies are anticipated to generate the highest revenue by 2035, with a projected valuation of 2.3 USD Billion.
What is the expected market value for liquid formulations in 2035?
The expected market value for liquid formulations in 2035 is 1.12 USD Billion.
How does the market for heart failure treatments compare to hypertension treatments in 2035?
In 2035, the market for heart failure treatments is projected to reach 1.8 USD Billion, compared to 2.3 USD Billion for hypertension treatments.
What is the projected market value for online pharmacies in 2035?
The projected market value for online pharmacies in 2035 is 2.12 USD Billion.
Descargar muestra gratis
Complete el formulario a continuación para recibir una muestra gratuita de este informe
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Estudio de caso
Aerospace & Defense
Deja un comentario